Genetic models of focal epilepsies

Journal of Neuroscience Methods

Volumn 260, Issue , 2016, Pages 132-143

  Boillot, Morgane ^a,b,c,d   Baulac, Stéphanie ^a,b,c,d  

^a INSERM   (France)

^b CNRS   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

Cellular and animal models; CHRNA4; CHRNB2; DEPDC5; Genetic focal epilepsies; KCNT1; LGI1

Indexed keywords

ION CHANNEL; MAMMALIAN TARGET OF RAPAMYCIN; NEUROTRANSMITTER RECEPTOR; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2; NERVE PROTEIN;

AUTOSOMAL DOMINANT EPILEPSY WITH AUDITORY FEATURE; AUTOSOMAL DOMINANT NOCTURNAL FRONTAL LOBE EPILEPSY; CHRNA2 GENE; CIRCADIAN RHYTHM; DEPDC5 GENE; ELECTROENCEPHALOGRAM; FOCAL EPILEPSY; GABAERGIC TRANSMISSION; GENE; GENE EXPRESSION SYSTEM; GENE MUTATION; GENETIC MODEL; HUMAN; KCNT1 GENE; LGI1 GENE; NERVE CELL GROWTH; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; GENETIC ENGINEERING; GENETIC PREDISPOSITION; GENETICS; MUTATION; PATHOPHYSIOLOGY; PROCEDURES; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; EPILEPSIES, PARTIAL; GENETIC ENGINEERING; GENETIC PREDISPOSITION TO DISEASE; ION CHANNELS; MUTATION; NERVE TISSUE PROTEINS; RECEPTORS, NEUROTRANSMITTER;

EID: 84957432205     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2015.06.003     Document Type: Review

References (125)

1. Anderson M.P. Arrested glutamatergic synapse development in human partial epilepsy. Epilepsy Curr/Am Epilepsy Soc 2010, 10:153-158.
2. Aridon P., Marini C., Di Resta C., Brilli E., De Fusco M., Politi F., et al. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet 2006, 79:342-350.
3. Barcia G., Fleming M.R., Deligniere A., Gazula V.R., Brown M.R., Langouet M., et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 2012, 44:1255-1259.
4. Baulac S. Genetics advances in autosomal dominant focal epilepsies: focus on DEPDC5. Prog Brain Res 2014, 213:123-139.
5. Baulac S., Ishida S., Marsan E., Miquel C., Biraben A., Nguyen D.K., et al. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann Neurol 2015, 77(April (4)):675-683.
6. Baulac S., Ishida S., Mashimo T., Boillot M., Fumoto N., Kuwamura M., et al. A rat model for LGI1-related epilepsies. Hum Mol Genet 2012, 21:3546-3557.
7. Bearden D., Strong A., Ehnot J., DiGiovine M., Dlugos D., Goldberg E.M. Targeted treatment of migrating partial seizures of infancy with quinidine. Ann Neurol 2014, 76:457-461.
8. Berghuis B., Brilstra E.H., Lindhout D., Baulac S., de Haan G.J., van Kempen M. Hyperactive behavior in a family with autosomal dominant lateral temporal lobe epilepsy caused by a mutation in the LGI1/epitempin gene. Epilepsy Behav: E&B 2013, 28:41-46.
9. Berkovic S.F., Izzillo P., McMahon J.M., Harkin L.A., McIntosh A.M., Phillips H.A., et al. LGI1 mutations in temporal lobe epilepsies. Neurology 2004, 62:1115-1119.
10. Bertrand D., Elmslie F., Hughes E., Trounce J., Sander T., Bertrand S., et al. The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits. Neurobiol Dis 2005, 20:799-804.
11. Bertrand D., Picard F., Le Hellard S., Weiland S., Favre I., Phillips H., et al. How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia 2002, 43(Suppl 5):112-122.
12. Bertrand S., Weiland S., Berkovic S.F., Steinlein O.K., Bertrand D. Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy. Br J Pharmacol 1998, 125:751-760.
13. Bisulli F., Tinuper P., Avoni P., Striano P., Striano S., d'Orsi G., et al. Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. Brain 2004, 127:1343-1352.
14. Blockus H., Chedotal A. The multifaceted roles of Slits and Robos in cortical circuits: from proliferation to axon guidance and neurological diseases. Curr Opin Neurobiol 2014, 27:82-88.
15. Boillot M., Huneau C., Marsan E., Lehongre K., Navarro V., Ishida S., et al. Glutamatergic neuron-targeted loss of LGI1 epilepsy gene results in seizures. Brain 2014, 137:2984-2996.
16. Chabrol E., Navarro V., Provenzano G., Cohen I., Dinocourt C., Rivaud-Pechoux S., et al. Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient mice. Brain 2010, 133:2749-2762.
17. Chabrol E., Popescu C., Gourfinkel-An I., Trouillard O., Depienne C., Senechal K., et al. Two novel epilepsy-linked mutations leading to a loss of function of LGI1. Arch Neurol 2007, 64:217-222.
18. Chen C., Westenbroek R.E., Xu X., Edwards C.A., Sorenson D.R., Chen Y., et al. Mice lacking sodium channel beta1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J Neurosci 2004, 24:4030-4042.
19. Chen Y., Wu L., Fang Y., He Z., Peng B., Shen Y., et al. A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy. Epilepsy Res 2009, 83:152-156.
20. Chernova O.B., Somerville R.P., Cowell J.K. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 1998, 17:2873-2881.
21. Cho Y.W., Motamedi G.K., Laufenberg I., Sohn S.I., Lim J.G., Lee H., et al. A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation. Arch Neurol 2003, 60:1625-1632.
22. Cho Y.W., Yi S.D., Lim J.G., Kim D.K., Motamedi G.K. Autosomal dominant nocturnal frontal lobe epilepsy and mild memory impairment associated with CHRNB2 mutation I312M in the neuronal nicotinic acetylcholine receptor. Epilepsy Behav: E&B 2008, 13:361-365.
23. Combi R., Dalpra L., Tenchini M.L., Ferini-Strambi L. Autosomal dominant nocturnal frontal lobe epilepsy-a critical overview. J Neurol 2004, 251:923-934.
24. Conti V., Aracri P., Chiti L., Brusco S., Mari F., Marini C., et al. Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function. Neurology 2015, 84(April (15)):1520-1528.
25. Dani J.A., Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 2007, 47:699-729.
26. Dazzo E., Santulli L., Posar A., Fattouch J., Conti S., Loden-van Straaten M., et al. Autosomal dominant lateral temporal epilepsy (ADLTE): novel structural and single-nucleotide LGI1 mutations in families with predominant visual auras. Epilepsy Res 2015, 110:132-138.
27. de Bellescize J., Boutry N., Chabrol E., Andre-Obadia N., Arzimanoglou A., Leguern E., et al. A novel three base-pair LGI1 deletion leading to loss of function in a family with autosomal dominant lateral temporal epilepsy and migraine-like episodes. Epilepsy Res 2009, 85:118-122.
28. De Fusco M., Becchetti A., Patrignani A., Annesi G., Gambardella A., Quattrone A., et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000, 26:275-276.
29. Di Bonaventura C., Carni M., Diani E., Fattouch J., Vaudano E.A., Egeo G., et al. Drug resistant ADLTE and recurrent partial status epilepticus with dysphasic features in a family with a novel LGI1 mutation: electroclinical, genetic, and EEG/fMRI findings. Epilepsia 2009, 50:2481-2486.
30. Di Bonaventura C., Operto F.F., Busolin G., Egeo G., D'Aniello A., Vitello L., et al. Low penetrance and effect on protein secretion of LGI1 mutations causing autosomal dominant lateral temporal epilepsy. Epilepsia 2011, 52:1258-1264.
31. Diaz-Otero F., Quesada M., Morales-Corraliza J., Martinez-Parra C., Gomez-Garre P., Serratosa J.M. Autosomal dominant nocturnal frontal lobe epilepsy with a mutation in the CHRNB2 gene. Epilepsia 2008, 49:516-520.
32. Dibbens L.M., de Vries B., Donatello S., Heron S.E., Hodgson B.L., Chintawar S., et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 2013, 45:546-551.
33. Fanciulli M., Santulli L., Errichiello L., Barozzi C., Tomasi L., Rigon L., et al. LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. Neurology 2012, 78:1299-1303.
34. Fertig E., Lincoln A., Martinuzzi A., Mattson R.H., Hisama F.M. Novel LGI1 mutation in a family with autosomal dominant partial epilepsy with auditory features. Neurology 2003, 60:1687-1690.
35. Figl A., Viseshakul N., Shafaee N., Forsayeth J., Cohen B.N. Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response. J Physiol 1998, 513(Pt 3):655-670.
36. Fonck C., Cohen B.N., Nashmi R., Whiteaker P., Wagenaar D.A., Rodrigues-Pinguet N., et al. Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4* nicotinic receptors. J Neurosci 2005, 25:11396-11411.
37. Fukata Y., Adesnik H., Iwanaga T., Bredt D.S., Nicoll R.A., Fukata M. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 2006, 313:1792-1795.
38. Fukata Y., Lovero K.L., Iwanaga T., Watanabe A., Yokoi N., Tabuchi K., et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci USA 2010, 107:3799-3804.
39. Grone B.P., Baraban S.C. Animal models in epilepsy research: legacies and new directions. Nat Neurosci 2015, 18:339-343.
40. Gu W., Brodtkorb E., Steinlein O.K. LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol 2002, 52:364-367.
41. Gullo F., Manfredi I., Lecchi M., Casari G., Wanke E., Becchetti A. Multi-electrode array study of neuronal cultures expressing nicotinic beta2-V287L subunits, linked to autosomal dominant nocturnal frontal lobe epilepsy. An in vitro model of spontaneous epilepsy. Front Neural Circuits 2014, 8:87.
42. Hedera P., Abou-Khalil B., Crunk A.E., Taylor K.A., Haines J.L., Sutcliffe J.S. Autosomal dominant lateral temporal epilepsy: two families with novel mutations in the LGI1 gene. Epilepsia 2004, 45:218-222.
43. Heiman G.A., Kamberakis K., Gill R., Kalachikov S., Pedley T.A., Hauser W.A., et al. Evaluation of depression risk in LGI1 mutation carriers. Epilepsia 2010, 51:1685-1690.
44. Heron S.E., Smith K.R., Bahlo M., Nobili L., Kahana E., Licchetta L., et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 2012, 44:1188-1190.
45. Hoda J.C., Gu W., Friedli M., Phillips H.A., Bertrand S., Antonarakis S.E., et al. Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore. Mol Pharmacol 2008, 74:379-391.
46. Irani S.R., Alexander S., Waters P., Kleopa K.A., Pettingill P., Zuliani L., et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010, 133:2734-2748.
47. Ishida S., Picard F., Rudolf G., Noe E., Achaz G., Thomas P., et al. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet 2013, 45:552-555.
48. Kalachikov S., Evgrafov O., Ross B., Winawer M., Barker-Cummings C., Martinelli Boneschi F., et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 2002, 30:335-341.
49. Kawamata J., Ikeda A., Fujita Y., Usui K., Shimohama S., Takahashi R. Mutations in LGI1 gene in Japanese families with autosomal dominant lateral temporal lobe epilepsy: the first report from Asian families. Epilepsia 2010, 51(April (4)):690-693.
50. Kegel L., Aunin E., Meijer D., Bermingham J.R. LGI proteins in the nervous system. ASN Neuro 2013, 5:167-181.
51. Kim E., Niethammer M., Rothschild A., Jan Y.N., Sheng M. Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases. Nature 1995, 378:85-88.
52. Kim G.E., Kronengold J., Barcia G., Quraishi I.H., Martin H.C., Blair E., et al. Human slack potassium channel mutations increase positive cooperativity between individual channels. Cell Rep 2014, 9:1661-1672.
53. Klaassen A., Glykys J., Maguire J., Labarca C., Mody I., Boulter J. Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy. Proc Natl Acad Sci USA 2006, 103:19152-19157.
54. Kobayashi E., Santos N.F., Torres F.R., Secolin R., Sardinha L.A., Lopez-Cendes I., et al. Magnetic resonance imaging abnormalities in familial temporal lobe epilepsy with auditory auras. Arch Neurol 2003, 60:1546-1551.
55. Krex D., Hauses M., Appelt H., Mohr B., Ehninger G., Schackert H.K., et al. Physical and functional characterization of the human LGI1 gene and its possible role in glioma development. Acta Neuropathol 2002, 103:255-266.
56. 2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. J Neurosci 1997, 17:9035-9047.
57. Lai M., Huijbers M.G.M., Lancaster E., Graus F., Bataller L., Balice-Gordon R., et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010, 9:776-785.
58. Lee M.K., Kim S.W., Lee J.H., Cho Y.J., Kim D.E., Lee B.I., et al. A newly discovered LGI1 mutation in Korean family with autosomal dominant lateral temporal lobe epilepsy. Seizure 2013, 23:69-73. (the journal of the British Epilepsy Association).
59. Leniger T., Kananura C., Hufnagel A., Bertrand S., Bertrand D., Steinlein O.K. A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy. Epilepsia 2003, 44:981-985.
60. Leonardi E., Andreazza S., Vanin S., Busolin G., Nobile C., Tosatto S.C.E. A computational model of the LGI1 protein suggests a common binding site for ADAM proteins. PLoS ONE 2011, 6:e18142.
61. Liu H., Lu C., Li Z., Zhou S., Li X., Ji L., et al. The identification of a novel mutation of nicotinic acetylcholine receptor gene CHRNB2 in a Chinese patient: its possible implication in non-familial nocturnal frontal lobe epilepsy. Epilepsy Res 2011, 95:94-99.
62. Lotfipour S., Byun J.S., Leach P., Fowler C.D., Murphy N.P., Kenny P.J., et al. Targeted deletion of the mouse alpha2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors. J Neurosci 2013, 33:7728-7741.
63. Manfredi I., Zani A.D., Rampoldi L., Pegorini S., Bernascone I., Moretti M., et al. Expression of mutant beta2 nicotinic receptors during development is crucial for epileptogenesis. Hum Mol Genet 2009, 18:1075-1088.
64. Marini C., Guerrini R. The role of the nicotinic acetylcholine receptors in sleep-related epilepsy. Biochem Pharmacol 2007, 74:1308-1314.
65. Martin H.C., Kim G.E., Pagnamenta A.T., Murakami Y., Carvill G.L., Meyer E., et al. Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis. Hum Mol Genet 2014, 23:3200-3211.
66. McLellan A., Phillips H.A., Rittey C., Kirkpatrick M., Mulley J.C., Goudie D., et al. Phenotypic comparison of two Scottish families with mutations in different genes causing autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia 2003, 44:613-617.
67. Michelucci R., Mecarelli O., Bovo G., Bisulli F., Testoni S., Striano P., et al. A de novo LGI1 mutation causing idiopathic partial epilepsy with telephone-induced seizures. Neurology 2007, 68:2150-2151.
68. Michelucci R., Pasini E., Nobile C. Lateral temporal lobe epilepsies: clinical and genetic features. Epilepsia 2009, 50(Suppl 5):52-54.
69. Michelucci R., Poza J.J., Sofia V., de Feo M.R., Binelli S., Bisulli F., et al. Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families. Epilepsia 2003, 44:1289-1297.
70. Milligan C.J., Li M., Gazina E.V., Heron S.E., Nair U., Trager C., et al. KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine. Ann Neurol 2014, 75:581-590.
71. Mitchell K.J., Pinson K.I., Kelly O.G., Brennan J., Zupicich J., Scherz P., et al. Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat Genet 2001, 28:241-249.
72. Morante-Redolat J.M., Gorostidi-Pagola A., Piquer-Sirerol S., Saenz A., Poza J.J., Galan J., et al. Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet 2002, 11:1119-1128.
73. Nobile C., Michelucci R., Andreazza S., Pasini E., Tosatto S.C., Striano P. LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum Mutat 2009, 30:530-536.
74. O'Neill H.C., Laverty D.C., Patzlaff N.E., Cohen B.N., Fonck C., McKinney S., et al. Mice expressing the ADNFLE valine 287 leucine mutation of the Beta2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function. Pharmacol Biochem Behav 2013, 103:603-621.
75. Ogawa Y., Oses-Prieto J., Kim M.Y., Horresh I., Peles E., Burlingame A.L., et al. a Kv1 channel-interacting protein, recruits membrane-associated guanylate kinases to juxtaparanodes of myelinated axons. J Neurosci 2010, 30:1038-1048.
76. Ohkawa T., Fukata Y., Yamasaki M., Miyazaki T., Yokoi N., Takashima H., et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 2013, 33:18161-18174.
77. Ottman R., Winawer M.R., Kalachikov S., Barker-Cummings C., Gilliam T.C., Pedley T.A., et al. LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 2004, 62:1120-1126.
78. Owuor K., Harel N.Y., Englot D.J., Hisama F., Blumenfeld H., Strittmatter S.M. LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology. Mol Cell Neurosci 2009, 42:448-457.
79. Phillips H.A., Favre I., Kirkpatrick M., Zuberi S.M., Goudie D., Heron S.E., et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 2001, 68:225-231.
80. Phillips H.A., Marini C., Scheffer I.E., Sutherland G.R., Mulley J.C., Berkovic S.F. A de novo mutation in sporadic nocturnal frontal lobe epilepsy. Ann Neurol 2000, 48:264-267.
81. Picard F., Baulac S., Kahane P., Hirsch E., Sebastianelli R., Thomas P., et al. Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families. Brain 2000, 123(Pt 6):1247-1262.
82. Picard F., Makrythanasis P., Navarro V., Ishida S., de Bellescize J., Ville D., et al. DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. Neurology 2014, 82:2101-2106.
83. Picard F., Pegna A.J., Arntsberg V., Lucas N., Kaczmarek I., Todica O., et al. Neuropsychological disturbances in frontal lobe epilepsy due to mutated nicotinic receptors. Epilepsy Behav: E&B 2009, 14:354-359.
84. Picard F., Scheffer I.E. Genetically determined focal epilepsies. Epileptic syndromes in infancy, childhood and adolescence montrouge 2012, 349-361. John Libbey Eurotext, Montrouge. M. Bureau, P. Genton, C. Dravet, A.V. Delgado-Escueta, C.A. Tassinari, P. Thomas, P. Wolf (Eds.).
85. Picciotto M.R., Zoli M., Lena C., Bessis A., Lallemand Y., Le Novere N., et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 1995, 374:65-67.
86. Pisano T., Marini C., Brovedani P., Brizzolara D., Pruna D., Mei D., et al. Abnormal phonologic processing in familial lateral temporal lobe epilepsy due to a new LGI1 mutation. Epilepsia 2005, 46:118-123.
87. Pizzuti A., Flex E., Di Bonaventura C., Dottorini T., Egeo G., Manfredi M., et al. Epilepsy with auditory features: a LGI1 gene mutation suggests a loss-of-function mechanism. Ann Neurol 2003, 53:396-399.
88. 2+ dependence of the mammalian alpha4beta2 acetylcholine response. J Physiol 2003, 550:11-26.
89. Rosanoff M.J., Ottman R. Penetrance of LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 2008, 71:567-571.
90. Ross S.A., Wong J.Y., Clifford J.J., Kinsella A., Massalas J.S., Horne M.K., et al. Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J Neurosci 2000, 20:6431-6441.
91. Rozycka A., Skorupska E., Kostyrko A., Trzeciak W.H. Evidence for S284L mutation of the CHRNA4 in a white family with autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia 2003, 44:1113-1117.
92. Sadleir L.G., Agher D., Chabrol E., Elkouby L., Leguern E., Paterson S.J., et al. Seizure semiology in autosomal dominant epilepsy with auditory features, due to novel LGI1 mutations. Epilepsy Res 2013, 107:311-317.
93. Saenz A., Galan J., Caloustian C., Lorenzo F., Marquez C., Rodriguez N., et al. Autosomal dominant nocturnal frontal lobe epilepsy in a Spanish family with a Ser252Phe mutation in the CHRNA4 gene. Arch Neurol 1999, 56:1004-1009.
94. Sagane K., Ishihama Y., Sugimoto H. LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11. Int J Biol Sci 2008, 4:387-396.
95. Sansoni V., Forcella M., Mozzi A., Fusi P., Ambrosini R., Ferini-Strambi L., et al. Functional characterization of a CRH missense mutation identified in an ADNFLE family. PLoS ONE 2013, 8:e61306.
96. Sansoni V., Nobili L., Proserpio P., Ferini-Strambi L., Combi R. A de novo mutation in an Italian sporadic patient affected by nocturnal frontal lobe epilepsy. J Sleep Res 2012, 21:352-353.
97. Scheel H., Tomiuk S., Hofmann K. A common protein interaction domain links two recently identified epilepsy genes. Hum Mol Genet 2002, 11:1757-1762.
98. Schulte U., Thumfart J.O., Klocker N., Sailer C.A., Bildl W., Biniossek M., et al. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron 2006, 49:697-706.
99. Senechal K.R., Thaller C., Noebels J.L. ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy. Hum Mol Genet 2005, 14:1613-1620.
100. Sirerol-Piquer M.S., Ayerdi-Izquierdo A., Morante-Redolat J.M., Herranz-Perez V., Favell K., Barker P.A., et al. The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface. Hum Mol Genet 2006, 15:3436-3445.
101. Smart S.L., Lopantsev V., Zhang C.L., Robbins C.A., Wang H., Chiu S.Y., et al. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 1998, 20:809-819.
102. Staub E., Perez-Tur J., Siebert R., Nobile C., Moschonas N.K., Deloukas P., et al. The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders. Trends Biochem Sci 2002, 27:441-444.
103. Steinlein O.K. Animal models for autosomal dominant frontal lobe epilepsy: on the origin of seizures. Expert Rev Neurother 2010, 10:1859-1867.
104. Steinlein O.K. Genetic heterogeneity in familial nocturnal frontal lobe epilepsy. Prog Brain Res 2014, 213:1-15.
105. Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F., et al. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet 1997, 6:943-947.
106. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995, 11:201-203.
107. Steinlein O.K., Stoodt J., Mulley J., Berkovic S., Scheffer I.E., Brodtkorb E. Independent occurrence of the CHRNA4 Ser248Phe mutation in a Norwegian family with nocturnal frontal lobe epilepsy. Epilepsia 2000, 41:529-535.
108. Striano P., Busolin G., Santulli L., Leonardi E., Coppola A., Vitiello L., et al. Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation. Neurology 2011, 76:1173-1176.
109. Striano P., de Falco A., Diani E., Bovo G., Furlan S., Vitiello L., et al. A novel loss-of-function LGI1 mutation linked to autosomal dominant lateral temporal epilepsy. Arch Neurol 2008, 65:939-942.
110. Tan H.O., Reid C.A., Single F.N., Davies P.J., Chiu C., Murphy S., et al. Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy. Proc Natl Acad Sci USA 2007, 104:17536-17541.
111. Teng Y., Xie X., Walker S., Rempala G., Kozlowski D.J., Mumm J.S., et al. Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotype. Hum Mol Genet 2010, 19:4409-4420.
112. Teng Y., Xie X., Walker S., Saxena M., Kozlowski D.J., Mumm J.S., et al. Loss of zebrafish lgi1b leads to hydrocephalus and sensitization to pentylenetetrazol induced seizure-like behavior. PLoS ONE 2011, 6:e24596.
113. Teper Y., Whyte D., Cahir E., Lester H.A., Grady S.R., Marks M.J., et al. Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation. J Neurosci 2007, 27:10128-10142.
114. Thomas R., Favell K., Morante-Redolat J., Pool M., Kent C., Wright M., et al. LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition. J Neurosci 2010, 30:6607-6612.
115. Wang M.Y., Liu X.Z., Wang J., Wu L.W. A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in a Chinese patient with non-familial nocturnal frontal lobe epilepsy. Epilepsy Res 2014, 108:1927-1931.
116. Weiland S., Witzemann V., Villarroel A., Propping P., Steinlein O. An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics. FEBS Lett 1996, 398:91-96.
117. Winawer M.R., Ottman R., Hauser W.A., Pedley T.A. Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology 2000, 54:2173-2176.
118. Xu J., Cohen B.N., Zhu Y., Dziewczapolski G., Panda S., Lester H.A., et al. Altered activity-rest patterns in mice with a human autosomal-dominant nocturnal frontal lobe epilepsy mutation in the beta2 nicotinic receptor. Mol Psychiatry 2011, 16:1048-1061.
119. Yamada J., Zhu G., Okada M., Hirose S., Yoshida S., Shiba Y., et al. A novel prophylactic effect of furosemide treatment on autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). Epilepsy Res 2013, 107:127-137.
120. Yokoi N., Fukata Y., Kase D., Miyazaki T., Jaegle M., Ohkawa T., et al. Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy. Nat Med 2015, 21:19-26.
121. Yu F.H., Mantegazza M., Westenbroek R.E., Robbins C.A., Kalume F., Burton K.A., et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006, 9:1142-1149.
122. Yu Y.E., Wen L., Silva J., Li Z., Head K., Sossey-Alaoui K., et al. Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability. Hum Mol Genet 2010, 19:1702-1711.
123. Zhou Y.D., Lee S., Jin Z., Wright M., Smith S.E., Anderson M.P. Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 2009, 15:1208-1214.
124. Zhou Y.D., Zhang D., Ozkaynak E., Wang X., Kasper E.M., Leguern E., et al. Epilepsy gene LGI1 regulates postnatal developmental remodeling of retinogeniculate synapses. J Neurosci 2012, 32:903-910.
125. Zhu G., Okada M., Yoshida S., Ueno S., Mori F., Takahara T., et al. Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype. J Neurosci 2008, 28:12465-12476.